Pulsara Logo

 

In this cohort of patients arriving during off hours, the utilization of Pulsara decreased the average door to balloon times by 10% in patients with acute STEMI. This effect was magnified when looking at the subset of all STEMI cases reportable to CMS. Further, we observed modest improvements in the less than 60 min D2B in patients arriving off-hour.

See the poster here. 

Questions? Just fill out the form and we will be in touch!